MétaCan
Menu
← Back to cohort
Record W4399359318 · doi:10.5489/cuaj.8822

Podium Session 3: Oncology – Bladder, Kidney, Testes

2024· article· en· W4399359318 on OpenAlexfundvenueaboutno aff
Editor CUAJ

Bibliographic record

VenueCanadian Urological Association Journal · 2024
Typearticle
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsnot available
FundersUniversity of TorontoBladder Cancer CanadaCanadian Urological Association Scholarship Fund
KeywordsMedicineBladder cancerAuditUrothelial cancerInternal medicineOncologyNephrologyProportional hazards modelProgression-free survivalUrologyCancerOverall survival

Abstract

fetched live from OpenAlex

Introduction: Current prognostic tools in non-muscle-invasive bladder cancer (nmIBC) perform poorly and do not fully reflect contemporary practices.We aimed to develop, externally validate, and conduct an algorithmic audit of a progression risk assessment tool using artificial intelligence approaches (progrxn-BCa).Methods: progrxn-BCa, based on a random survival forest, was trained on nmIBC patients treated from January 1, 2005, to June 30, 2022, at four Canadian academic or community hospitals.external validation was performed on patients treated from november 1, 2011, to september 11, 2023, across 13 institutions from the Canadian Bladder Cancer information system.the primary outcome was time to progression, defined as first development of muscle-invasive or metastatic disease.progrxn-BCa was compared to the european Association of Urology risk calculator and a lAsso Cox model using identical variables as progrxn-BCa.model performance in predicting five-year progression risk was characterized using c-index, calibration plots, decision curve analysis, and an algorithmic audit.Results: overall, 999 of 7032 patients (14%) developed progression during a median followup of 3.0 years (IQr 1.4-5.4).progrxn-BCa had the highest c-index overall (training: 0.83, 95% CI 0.81-0.84;validation: 0.76, 95% CI 0.74-0.77)and across different subgroups.It was well-calibrated and had the highest net benefit for clinically relevant thresholds from 15-40%.False negatives occurred in only 2-6% of all predictions, most commonly found in patients with ta disease.progrxn-BCa could better substratify intermediate-risk patients compared to current guideline recommendations, reclassifying 12% of these patients with an observed five-year progression risk of 31.6% who otherwise would not have been considered for treatment intensification or clinical trial enrollment (Figure 1).Conclusions: progrxn-BCa outperformed current prognostication tools and improved substratification of the heterogenous intermediate-risk group.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesInsufficient payload (model declined to judge)
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: Other
Teacher disagreement score0.690
Threshold uncertainty score0.985

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.006
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.004
Research integrity0.0030.004
Insufficient payload (model declined to judge)0.3100.148

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.284
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes3
Has abstractyes

Explore more

Same venueCanadian Urological Association Journal→Same topicBladder and Urothelial Cancer Treatments→French-language works237,207→